Plasma osteopontin concentrations in patients with cutaneous melanoma

An effective circulating tumour marker is needed for melanoma especially with the advent of targeted therapies. Gene expression studies examining primary melanomas have shown that increased expression of osteopontin (SPP1) is associated with poor prognosis. Studies subsequently reported higher blood...

Descripción completa

Detalles Bibliográficos
Autores principales: FILIA, A., ELLIOTT, F., WIND, T., FIELD, S., DAVIES, J., KUKALIZCH, K., RANDERSON-MOOR, J., HARLAND, M., BISHOP, D.T., BANKS, R.E., NEWTON-BISHOP, J.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810214/
https://www.ncbi.nlm.nih.gov/pubmed/23934016
http://dx.doi.org/10.3892/or.2013.2666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810214/
https://www.ncbi.nlm.nih.gov/pubmed/23934016
http://dx.doi.org/10.3892/or.2013.2666

Ejemplares similares